ClinicalTrials.Veeva

Menu

Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Low Back Pain

Treatments

Behavioral: Psychoeducation
Behavioral: Mindfulness-Oriented Recovery Enhancement: (MORE) group

Study type

Interventional

Funder types

Other

Identifiers

NCT06268522
2023P001582

Details and patient eligibility

About

This study is a Randomized Controlled Trial exploring the effects of a Mindfulness interventions in reducing pain interference and opioid dose in patients with Chronic Low Back Pain. A total of 200 opioid-using patients with chronic pain, male and female participants will be enrolled, with a need for 160 completers. Patient will be randomly assigned into the Mindfulness-Oriented Recovery Enhancement or the Psychoeducation comparison control group.

Enrollment

121 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age>18yo
  • Chronic Low Back Pain as seen on medical history as well as score of >3 on pain visual analog scale (VAS) at the start of experimental sessions.
  • receiving prescription opioids for three or more months and planning to start tapering their opioids with their provider.
  • willing to be randomized to one of the two behavioral treatment. Patients referred or self-referred to the study from an outside clinic will also be able to participate (we will be in contact with their prescribing provider)
  • able and willing to perform/tolerate pain procedures (e.g., QST)
  • able to communicate fluently in English
  • able to use a smartphone or laptop for the virtual therapy program

Exclusion criteria

  • Current illicit substance use (e.g marijuana use will be exempted) at screening or during trial as verified by urine toxicology screen and/or self-report for all participants;
  • Medical condition known to influence QST or participation in the MORE intervention; serious psychiatric condition;
  • regular meditation practice
  • cognitive impairment
  • pregnancy
  • lack of English fluency
  • severe OUD
  • inability to provide informed consent.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

121 participants in 2 patient groups, including a placebo group

Mindfulness-Oriented Recovery Enhancement: (MORE) group
Experimental group
Treatment:
Behavioral: Mindfulness-Oriented Recovery Enhancement: (MORE) group
Psychoeducation
Placebo Comparator group
Treatment:
Behavioral: Psychoeducation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems